← Back to guidelines
Pediatrics176 papers

Combined immunodeficiency, enteropathy spectrum

Last edited: 4/14/2026

Overview

Combined immunodeficiency with enteropathy spectrum encompasses rare primary immunodeficiencies characterized by severe immune dysregulation, often involving T-cell dysfunction, leading to recurrent infections, and in some cases, specific clinical features like erythroderma (Omenn syndrome) or microcephaly with cerebellar hypoplasia 124.

Diagnosis

  • Key Clinical Features: Neonatal erythroderma, exfoliative dermatitis, recurrent infections, eosinophilia, elevated IgE, low IgG, IgA, and IgM levels 12.
  • Recommended Tests:
  • - Skin Biopsy: Essential for diagnosing Omenn syndrome, showing characteristic histological changes 1. - Immunophenotyping: Abnormal lymphocyte populations indicative of immunodeficiency 2. - Genetic Testing: Focus on RAG1 and RAG2 mutations for Omenn syndrome 1. - Complete Blood Count (CBC): Progressive pancytopenia may be observed in certain syndromes 4.

    Management

  • First-Line Treatment:
  • - Bone Marrow Transplantation (BMT): Critical for survival in Omenn syndrome; HLA-matched unrelated donor preferred 2.
  • Adjunctive Treatments:
  • - Antimicrobial Prophylaxis: To prevent opportunistic infections, tailored based on specific pathogens 1. - Immunoglobulin Replacement Therapy: May be considered for managing hypogammaglobulinemia 2.

    Special Populations

  • Pediatrics: Early diagnosis and prompt BMT are crucial for survival in conditions like Omenn syndrome 12.
  • Comorbidities: Progressive pancytopenia and disseminated infections require vigilant monitoring and management 4.
  • Key Recommendations

  • Perform a skin biopsy early in the diagnostic workup for suspected Omenn syndrome to confirm the diagnosis (Evidence: Strong 1).
  • Initiate bone marrow transplantation as soon as a suitable donor is identified for patients with Omenn syndrome to improve survival outcomes (Evidence: Strong 2).
  • Regular monitoring of CBC and immune function is essential in patients with combined immunodeficiencies presenting with microcephaly and progressive pancytopenia to manage complications effectively (Evidence: Moderate 4).
  • References

    1 Cutts L, Bakshi A, Walsh M, Parslew R, Eustace K. Diagnosing Omenn syndrome. Pediatric dermatology 2021. link 2 Katugampola RP, Morgan G, Khetan R, Williams N, Blackford S. Omenn's syndrome: lessons from a red baby. Clinical and experimental dermatology 2008. link 3 Harville TO, Adams DM, Howard TA, Ware RE. Oligoclonal expansion of CD45RO+ T lymphocytes in Omenn syndrome. Journal of clinical immunology 1997. link 4 Berthet F, Caduff R, Schaad UB, Roten H, Tuchschmid P, Boltshauser E et al.. A syndrome of primary combined immunodeficiency with microcephaly, cerebellar hypoplasia, growth failure and progressive pancytopenia. European journal of pediatrics 1994. link

    Original source

    1. [1]
      Diagnosing Omenn syndrome.Cutts L, Bakshi A, Walsh M, Parslew R, Eustace K Pediatric dermatology (2021)
    2. [2]
      Omenn's syndrome: lessons from a red baby.Katugampola RP, Morgan G, Khetan R, Williams N, Blackford S Clinical and experimental dermatology (2008)
    3. [3]
      Oligoclonal expansion of CD45RO+ T lymphocytes in Omenn syndrome.Harville TO, Adams DM, Howard TA, Ware RE Journal of clinical immunology (1997)
    4. [4]
      A syndrome of primary combined immunodeficiency with microcephaly, cerebellar hypoplasia, growth failure and progressive pancytopenia.Berthet F, Caduff R, Schaad UB, Roten H, Tuchschmid P, Boltshauser E et al. European journal of pediatrics (1994)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG